Clinical Trial Update: Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated brexpiprazole as an adjunctive treatment for irritability in adults with major depressive disorder who did not adequately respond to a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Brexpiprazole (Rexulti) (brexpiprazole)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder, Irritability | Phase 3 | Status: COMPLETED | Results posted: 2016-03-15